Wolverine Trading
PCRX icon

Wolverine Trading’s Pacira BioSciences PCRX Stock Holding History

Wolverine Trading’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,058
Closed -$220K – 4771
2022
Q3 		$220K Buy
+4,058
New +$226K ﹤0.01% 3501
2019
Q1 		– Sell
-9,756
Closed -$381K – 5106
2018
Q4 		$415K Buy
+9,756
New +$455K ﹤0.01% 2826
2016
Q4 		– Sell
-20,539
Closed -$685K – 4958
2016
Q3 		$699K Buy
+20,539
New +$805K ﹤0.01% 2251

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading's PCRX Position: Q4 2022 in Review

Wolverine Trading sold out of Pacira BioSciences (PCRX) in Q4 2022, closing a stake of 4,058 shares — an estimated $220K sold.

Wolverine Trading first reported a position in PCRX in Q3 2016 and held it in 3 quarters. The position peaked at $699K in Q3 2016. 273 funds tracked by Wall St. Rank hold PCRX as of Q4 2022.

  • Wolverine Trading reported no remaining Pacira BioSciences position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 4,058 Pacira BioSciences shares in Q4 2022, an estimated $220K.
  • Wolverine Trading first reported a position in Pacira BioSciences in Q3 2016 and held it in 3 quarters.
  • Wolverine Trading's Pacira BioSciences position peaked at $699K in Q3 2016.
  • 273 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.